v3.26.1
Cash, Cash Equivalents and Marketable Securities
6 Months Ended
Jun. 30, 2026
Cash and Cash Equivalents [Abstract]  
Cash, Cash Equivalents and Marketable Securities Cash, Cash Equivalents and Marketable Securities
The Company maintains certain cash balances restricted as to withdrawal or use. Restricted cash consists of cash deposits received from future astronauts that are contractually restricted for operational use until the condition of carriage is signed or the deposits are refunded.
The amortized cost, unrealized gain (loss) and estimated fair value of the Company’s cash, cash equivalents and marketable securities are as follows:
June 30, 2026
Amortized CostGross Unrealized LossFair Value
(In thousands)
Cash and cash equivalents:
Cash and restricted cash$12,865 $— $12,865 
Money market205,547 — 205,547 
Marketable securities:
U.S. treasuries59,672 (8)59,664 
Corporate bonds8,052 (2)8,050 
$286,136 $(10)$286,126 

December 31, 2025
Amortized Cost
Gross Unrealized Gain
Fair Value
(In thousands)
Cash and cash equivalents:
Cash and restricted cash$7,687 $— $7,687 
Money market168,028 — 168,028 
Marketable securities:
U.S. treasuries9,884 14 9,898 
Corporate bonds152,372 43 152,415 
$337,971 $57 $338,028 

Interest receivable of $0.5 million and $2.0 million is included in other current assets in the accompanying condensed consolidated balance sheets as of June 30, 2026 and December 31, 2025, respectively.
The Company recognizes amortization and accretion of purchase premiums and discounts on its marketable securities in interest income in the accompanying condensed consolidated statements of operations and comprehensive loss. The Company recognized $0.4 million and $1.8 million in accretion income for its marketable securities for the three months ended June 30, 2026 and 2025, respectively. The Company recognized $0.8 million and $4.0 million in accretion income for its marketable securities for the six months ended June 30, 2026 and 2025, respectively.